NCT06056336
- Conditions
- Adjuvant Therapy, Carcinoma, Carcinoma, Squamous Cell, +14 more
- Locations
-
- Shanghai chest hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Adjuvant Therapy
Explore clinical trials studying Adjuvant Therapy. Study availability and eligibility vary by location and protocol.
27 public trials
13 recruiting studies
Adjuvant Therapy trial results
NCT06041776
- Conditions
- Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Peking University International Hospital Beijing, China
- Jiangsu Cancer Hospital Nanjing, China
- Shanghai chest hospital Shanghai, China
NCT05292742
- Conditions
- Adjuvant Therapy, Breast Cancer, Breast Diseases, +5 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
Not Yet Recruiting
A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs.
NCT07686185
- Conditions
- Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
Not Yet Recruiting
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT07303283
- Conditions
- Adjuvant Therapy, Carcinoma, Head and Neck Neoplasms, +14 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
Not Yet Recruiting
A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer
NCT07466901
- Conditions
- Adjuvant Therapy, Cervical Cancer, Female Urogenital Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Not Yet Recruiting
Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma
NCT07379489
- Conditions
- Adjuvant Therapy, Disease Attributes, HCC, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
NCT07101159
- Conditions
- Adjuvant Therapy, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
Not specified
Not Yet Recruiting
Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma
NCT07092449
- Conditions
- Adjuvant Therapy, Gastric / Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction, +1 more
- Locations
-
Not specified
Not Yet Recruiting
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer
NCT07005557
- Conditions
- Adjuvant Therapy, Breast Cancer, Breast Diseases, +5 more
- Locations
-
Not specified